Showing posts with label failed Alzheimer's drugs. Show all posts
Showing posts with label failed Alzheimer's drugs. Show all posts

Cinnamon beats Alzheimers



'The miracle spice cinnamon is the scented bark of a tropical evergreen tree, native to India and Sri Lanka. Cinnamon comes from an evergreen tree in Southeast Asia and is cultivated widely in Vietnam, China, Burma, and Laos for its bark and the oil processed from the bark. Once upon a time in ancient Rome, cinnamon was worth more than silver.

Cinnamon is harvested from the inner bark of the tree branches after scraping off the corky outer layer and then drying the bark. As it dries, the bark curls up into quills which are then cut into sticks to be ground into the spice form. Full of calcium and fiber, cinnamon is one of the oldest known spices, it is mentioned in the Bible and was used in ancient Egypt as medicine, beverage flavoring and an embalming agent.'





Read more...




>>>READ MORE

Failed Alzheimer's Drug Reveals Pharmaceutical Shell Game

Big Pharma is Not Interested in Helping People!

'Given a worst-case scenario, the principals of Medivation have made themselves rich, even if they never produce a single product. If they do, then they'll become fabulously rich—even if their products produce only marginal benefits or do significant harm. Their positions within the corporation insulate them from most risk—a significantly different position from those who take their products in the hope of gaining some marginal benefit.

Think about it: The excitement over Dimebon relates to an improvement of 1.3 points over other drugs on a scale of 0-70 in the Alzheimer's Disease Assessment Scale, cognitive section—and there's no indication of arresting the disease.

For, at best, minimal benefit to patients, a small number of people who know how to play the system are, at a minimum, raking in millions on the hope of achieving that small gain. If they hit the jackpot, they stand to see profits in the tens or hundreds of millions of dollars.

Quite a scam, isn't it?'


Read more...





>>>READ MORE